1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. SAREPTA THERAPEUTICS INC
Sarepta Therapeutics Inc XNAS: SRPT

Sarepta Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Expensive Underperformer
about

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targ...

Read More
17.54 -1.27 (-6.75%)
87.36% Fall from 52W High
4.4M
XNAS Volume

XNAS 17 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
27.3 / 100
Momentum Score
Technically Bearish
20.0 / 100
Expensive Underperformer These stocks are medium in financial scores. They have bad valuation and technical scores as well. View Similar Embed DVM
Analyst Price Target
21
1Yr Price target upside is 22%
22 analysts

11

S

16

W

3

O

2

T

SWOT Analysis

Sarepta Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..